TrialThe Lancet. Global health2021

Efficacy and cost-effectiveness of a community-based smoke-free-home intervention with or without indoor-air-quality feedback in Bangladesh (MCLASS II): a three-arm, cluster-randomised, controlled trial.

Noreen Dadirai Mdege et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.